Phase I/II Study of Carboplatin, Melphalan and Etoposide Phosphate in Conjunction with Osmotic Opening of the Blood-Brain Barrier and Delayed Intravenous Sodium Thiosulfate Chemoprotection, in Previously Treated Subjects with Anaplastic Oligodendroglioma or Oligoastrocytoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melphalan (Primary) ; Carboplatin; Etoposide; Etoposide phosphate; Filgrastim; Pegfilgrastim
- Indications Anaplastic astrocytoma; Glioma; Oligodendroglioma
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 24 May 2021 Biomarkers information updated
- 30 Jul 2013 Planned end date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 02 Jun 2012 Additional lead trial centre added as reported by Oregon Health and Science University record.